EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)

Alina Sprenger-Svačina, Ines Klein, Martin K R Svačina, Ilja Bobylev, Felix Kohle, Christian Schneider, Finja Schweitzer, Nadin Piekarek, Mohammed Barham, Maria J G T Vehreschild, Helmar C Lehmann, Fedja Farowski

Journal of Neuroimmune Pharmacology · 2024

DOI: 10.1007/s11481-024-10119-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroimmune Pharmacology, 2024. Verfasst von Alina Sprenger-Svačina und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany. alina.sprenger-svacina@uk-k…. Hauptthemen laut MEDLINE: Rats, Inbred Lew, Neuritis, Autoimmune, Experimental, Gastrointestinal Microbiome, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Köln.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background The composition of gut microbiota plays a pivotal role in priming the immune system and thus impacts autoimmune diseases. Data on the effects of gut bacteria eradication via systemic antibiotics on immune neuropathies are currently lacking. This study therefore assessed the effects of antibiotics-induced gut microbiota alterations on the severity of experimental autoimmune neuritis (EAN), a rat model of Guillain-Barré Syndrome (GBS). Myelin P0 peptide 180–199 (P0 180–199)-induced EAN severity was compared between adult Lewis rats (12 weeks old) that received drinking water with or without antibiotics (colistin, metronidazole, vancomycin) and healthy rats, beginning antibiotics treatment immediately after immunization (day 0), and continuing treatment for 14 consecutive days. Neuropathy severity was assessed via a modified clinical score, and then related to gut microbiota alterations observed after fecal 16S rRNA gene sequencing at baseline and after EAN induction. Effectors of gut mucosal and endoneurial immunity were assessed via immunostaining. EAN rats showed increased gut mucosal permeability alongside increased mucosal CD8 + T cells compared to healthy controls. Antibiotics treatment alleviated clinical EAN severity and reduced endoneurial T cell infiltration, decreased gut mucosal CD8 + T cells and increased gut bacteria that may be associated with anti-inflammatory mechanisms, like Lactobacillus or Parasutterella . Our findings point out a relation between gut mucosal immunity and the pathogenesis of EAN, and indicate that antibiotics-induced intestinal immunomodulation might be a therapeutic approach to alleviate autoimmunity in immune neuropathies. Further studies are warranted to evaluate the clinical transferability of these findings to patients with GBS. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rats, Inbred LewNeuritis, Autoimmune, ExperimentalGastrointestinal MicrobiomeAnti-Bacterial AgentsImmunomodulationAnimalsRatsMale

Stichwörter der Autor:innen

AutoimmunityGuillain-Barré Syndrome (GBS)Gut microbiotaImmune neuropathiesIntestinal barrier

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Neurology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany. alina.sprenger-svacina@uk-koeln.de.
  • Department of Neurology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Department of Neurology, St. Katharinen-Hospital, Frechen, Germany.
  • Experimental Medicine, Faculty of Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Department II of Anatomy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.

Förderung

  • Universitätsklinikum Köln

Zitieren

APA

Sprenger-Svačina, A., Klein, I., Svačina, M. K. R., Bobylev, I., Kohle, F., Schneider, C., Schweitzer, F., Piekarek, N., Barham, M., Vehreschild, M. J. G. T., Lehmann, H. C., & Farowski, F. (2024). Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN). Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-024-10119-9

Vancouver

Sprenger-Svačina A, Klein I, Svačina MKR, Bobylev I, Kohle F, Schneider C, et al. Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN). Journal of Neuroimmune Pharmacology. 2024. doi:10.1007/s11481-024-10119-9

BibTeX
@article{SprengerSvaina2024,
  author = {Sprenger-Svačina, Alina and Klein, Ines and Svačina, Martin K R and Bobylev, Ilja and Kohle, Felix and Schneider, Christian and Schweitzer, Finja and Piekarek, Nadin and Barham, Mohammed and Vehreschild, Maria J G T and Lehmann, Helmar C and Farowski, Fedja},
  title = {Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)},
  journal = {Journal of Neuroimmune Pharmacology},
  year = {2024},
  doi = {10.1007/s11481-024-10119-9}
}
Kostenlos starten →